Japan, Oct. 5 -- DENALI THERAPEUTICS INC has got intellectual property rights for 'FORMULATIONS OF PROTEIN MOLECULES COMPRISING IDURONATE 2-SULFATASE.' Other related details are as follows:

Application Number: JP,2025-120522

Category (FI): A61K9/08,A61K9/19,A61K47/20,A61K47/18,C12N9/16@Z,C12N15/62@Z,C12N15/55,C12N15/13,C07K19/00,C07K14/47,A61K38/46,A61K47/12,A61K47/02,A61K47/26,C07K16/00,A61P3/00,A61K9/10

Stage: Grant (IP right granted following substantive examination.)

Filing Date: July 17, 2025

Publication Date: Oct. 7, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....